Comparison of the activities of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids of rheumatoid arthritis and osteoarthritis patients

Rheumatology

Volumn 43, Issue 4, 2004, Pages 435-441

  Takano, H ^a,b   Tomita, T ^a   Toyosaki Maeda, T ^c   Maeda Tanimura, M ^c   Tsuboi, H ^a   Takeuchi, E ^a   Kaneko, M ^a   Shi, K ^a   Takahi, K ^a   Myoui, A ^a   Yoshikawa, H ^a   Takahashi, T ^b   Suzuki, R ^d   Ochi, T ^a,d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU DENTAL COLLEGE   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

^d SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

CD14 positive cell; Osteoclast; Rheumatoid arthritis; Synovial fluid

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACTIN; CALCITONIN RECEPTOR; CARBONATE DEHYDRATASE II; CD14 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 7; VITRONECTIN RECEPTOR;

ADULT; AGED; ARTICLE; BONE DESTRUCTION; CELL ACTIVITY; CELL CULTURE; CELL FUNCTION; CELL FUSION; CELL NUCLEUS; CELL SELECTION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GIANT CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; OSTEOARTHRITIS; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ANTIGENS, CD14; ARTHRITIS, RHEUMATOID; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; FEMALE; GIANT CELLS; HUMANS; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL FLUID;

EID: 11144354669     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh077     Document Type: Article

References (42)

1. Athanasou NA. Cellular biology of bone resorbing cells. J Bone Joint Surg 1996;78A:1096-112.
2. Akagawa KS, Takatsuka N, Nozaki Y et al. Generation of CD1+ Re1B+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 1996;88:4029-39.
3. Matayoshi A, Brown C, DiPersio JF et al. Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc Natl Acad Sci USA 1996;93:10785-90.
4. Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 1984;27:968-75.
5. Hagenaars CE, Van der Kraan AA, Kawilarang-de Haas EW, Visser JW, Nijweide PJ. Osteoclast formation from cloned pluripotent hemopoietic stem cells. Bone Miner 1989;6:179-89.
6. Sheven BA, Viser JW, Nijweide PJ. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 1986;321:79-81.
7. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 1992;13:66-80.
8. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Isogai Y, Suda T. Deficiency of osteoclasts in osteoporotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology 1991;128:1792-6.
9. Tamura T, Udagawa N, Takahashi N et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA 1993;90:11924-8.
10. Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-602.
11. Takayanagi H, Oda H, Yamamoto S et al. A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis. Biochem Biophys Res Commun 1997;240:279-86.
12. Fujikawa Y, Shingu M, Torisu T, Itonaga I, Masumi S. Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium. Br J Rheumatol 1996;35:213-7.
13. Fujikawa Y, Sabokbar A, Nealev S, Athanasou NA. Human osteoclast formation by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis 1996;55:816-22.
14. Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ, Cohen G. Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1982;2:49-53.
15. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum 1983;26:975-83.
16. Nouri AM, Panayi GS, Goodman SM. Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 1984;55:295-302.
17. Miossec P, Dinarello CA, Ziff M. Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 1986;29:461-70.
18. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
19. Hirano T, Matsuda T, Turner M et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988;18:1797-801.
20. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 1989;83:585-92.
21. Kotake S, Sato K, Kim KJ et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996;11:88-95.
22. Kotake S, Udagawa N, Takahashi N et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345-52.
23. Manabe N, Oda H, Nakamura K, Kuga Y, Uchida S, Kawaguchi H. Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients. Rheumatology 1999;38:714-20.
24. Wekerle H, Ketelsen UP, Ernst M. Thymic nurse cells: Lymphoepithelial cell complexes in murine thymuses: morphological and serological characterization. J Exp Med 1980;151:925-44.
25. Wekerle H, Ketelsen UP. Thymic nurse cells: Ia-bearing epithelium involved in T-lymphocyte differentiation? Nature 1980;283:402-4.
26. Brelinska R, Seidel HJ, Kreja L. Thymic nurse cells: differentiation of thymocytes within complexes. Cell Tissue Res 1991;264:175-83.
27. Pezzano M, Li Y, Philp D, Omene C, Cantey M, Saunders G. Thymic nurse cell rescue of early CD4+ CD8+ thymocytes from apoptosis. Cell Mol Biol (Noisy-le-grand) 1995;41:1099-111.
28. Hiramine C, Nakagawa T, Miyauchi A, Hojo K. Thymic nurse cells as the site of thymocyte apoptosis and apoptotic cell clearance in the thymus of cyclophosphamide-treated mice. Lab Invest 1996;75:185-201.
29. Takeuchi E, Tomita T, Toyosaki-Maeda T et al. Establishment and characterization of nurse cell-like stromal cell lines from synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 1999;42:221-8.
30. Tomita T, Takeuchi E, Toyosaki-Maeda T et al. Establishment of nurse cell-like stromal cells from bone marrow of patients with rheumatoid arthritis: indication of characteristic bone marrow microenvironment in patients with rheumatoid arthritis. Rheumatology 1999;38:854-63.
31. Shimaoka Y, Attrep JF, Hirano T et al. Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells. J Clin Invest 1998;102:606-18.
32. Toyosaki-Maeda T, Takano H, Tomita T et al. Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines. Arthritis Res 2001;3:306-10.
33. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
34. Higuchi S, Tabata N, Tajima M et al. Induction of human osteoclast-like cells by treatment of blood monocytes with anti-fusion regulatory protein-1/CD98 monoclonal antibodies. J Bone Miner Res 1998;13:44-9.
35. Toyosaki T, Tsuruta Y, Yoshioka T et al. Recognition of rheumatoid arthritis synovial antigen by CD4+, CD8- T cell clones established from rheumatoid arthritis. Arthritis Rheum 1988;41:92-100.
36. Kitamura T, Sato N, Arai K, Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 1991;66:1165-74.
37. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol, 1992;31:653-61.
38. Bell AL, Magill KK, McKane WR, Kirk F, Irvine AE. Measurement of colony-stimulating factors in synovial fluid: potential clinical value. Rheumatol Int 1995;14:177-82.
39. Lacey DL, Timms E. Tan HL et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 108;17:165-76.
40. Kong YY, Yoshida H, Sarosi I et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;28:315-23.
41. Ashton BA, Ashton IK, Marshall MJ, Butler RC. Localization of vitronectin receptor immunoreactivity and tartrate resistant acid phosphatase activity in synovium from patients with inflammatory or degenerative arthritis. Ann Rheum Dis 1993;52:133-7.
42. Suzuki Y, Tsutsumi Y, Nakagawa M et al. Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium. Rheumatology 2001;40:673-82.